Bile duct disorders can lead to serious complications if left untreated, but early diagnosis and proper management can ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Year-end Report January-December 2024. The full report is available on the Company's website. "Stronger ...

Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeli ...

In a recent study published in the Journal of Crohn’s and Colitis, researchers showed that oral vancomycin (OV) induces clinical remission in primary sclerosing cholangitis-associated inflammatory ...

A study led by the University of Birmingham found that vancomycin, a commonly used antibiotic for diarrhea, could effectively ...

An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.

An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study published in the Journal of Crohn's and Colitis has found.

Objectives Primary sclerosing cholangitis (PSC) is a rare chronic disease that presents challenges to both patients and ...

Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success. Click for my GILD stock update.

Follow-up of patients is life-long and must address treatment of the disease and management of associated symptoms. autoimmune liver disease care pathway guidelines ursodeoxycholic acid obeticholic ...

Will treatment against one condition then worsen the other? Regarding the effect of biliary disease on colitis, there are some open questions following the presented experiments. The study by Bedtke ...